首页> 美国卫生研究院文献>other >Plasma Stromal Cell-Derived Factor 1α/CXCL12 Level Predicts Long-Term Adverse Cardiovascular Outcomes in Patients with Coronary Artery Disease

【2h】

Plasma Stromal Cell-Derived Factor 1α/CXCL12 Level Predicts Long-Term Adverse Cardiovascular Outcomes in Patients with Coronary Artery Disease

机译：血浆基质细胞衍生因子1α/ CXCL12水平可预测冠状动脉疾病患者的长期不良心血管事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveStromal derived factor-1α/CXCL12 is a chemoattractant responsible for homing of progenitor cells to ischemic tissues. We aimed to investigate the association of plasma CXCL12 with long-term cardiovascular outcomes in patients with coronary artery disease (CAD).

机译：目的Stromal衍生因子-1α/ CXCL12是一种化学引诱剂，负责将祖细胞归巢到缺血组织。我们旨在研究血浆CXCL12与冠心病（CAD）患者的长期心血管结局的关系。

著录项

期刊名称 other
作者
Nima Ghasemzadeh; Abdul Wahab Hritani; Christine De Staercke; Danny J. Eapen; Emir Veledar; Hatem Al Kassem; Mohamed Khayata; A. Maziar Zafari; Laurence Sperling; Craig Hooper; Viola Vaccarino; Kreton Mavromatis; Arshed A. Quyyumi;
展开▼
作者单位

展开▼
年(卷),期 -1(238),1
年度 -1
页码 113–118
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
Stromal Cell-Derived Factor1α CXCL12 coronary artery disease cardiovascular outcomes;

机译：基质细胞衍生因子1α;CXCL12;冠状动脉疾病;心血管预后;

相似文献

外文文献
中文文献
专利

1. Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: Effect of clinical presentation and cardiovascular risk factors [J] . StellosK., RufM., SopovaK., Atherosclerosis . 2011,第2期

机译：冠状动脉疾病患者血浆中基质细胞源性因子1的水平：临床表现和心血管危险因素的影响
2. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease [J] . IIS-Fundaci贸nJim茅nezD铆azMadrid, Aut贸nomaUniversityMadrid, HospitaldeFuenlabradaFuenlabrada, Diabetes/metabolism research and reviews . 2016,第7期

机译：循环中成纤维细胞生长因子-23血浆水平预测患有冠心病的糖尿病患者的不良心血管结果
3. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus [J] . Aritaka Makino, Takamitsu Nakamura, Mitsumasa Hirano, Atherosclerosis . 2010,第2期

机译：血浆高水平的巨噬细胞迁移抑制因子与稳定冠状动脉疾病和糖耐量受损或2型糖尿病患者的长期不良预后相关
4. Mass Spectrometric Study of the Truncation of Stromal Cell-derived Factor-1 (SDF-1) by Proteolytic Enzymes in Patients with Myeloproliferative Diseases [C] . Sool Yeon Cho, Mingjiang Xu, Pratibha Singh, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：骨髓溶胶患者蛋白水解酶对基质细胞衍生因子-1（SDF-1）截短的质谱研究
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease [O] . José Tuñón, Carmen Cristóbal, Nieves Tarín, -1

机译：低维生素D和高成纤维细胞生长因子23血浆水平的共存可预测冠状动脉疾病患者的不良结果
7. STROMAL CELL-DERIVED FACTOR 1- AND CIRCULATING PROGENITOR CELL LEVELS AS PREDICTORS OF ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE [O] . Ghasemzadeh Nima, De Staercke Christine, Li Qunna, 2014

机译：冠状动脉疾病患者冠状动脉源性基质细胞因子1-和循环祖细胞水平预测不良心血管结果

Plasma Stromal Cell-Derived Factor 1α/CXCL12 Level Predicts Long-Term Adverse Cardiovascular Outcomes in Patients with Coronary Artery Disease

摘要

著录项

相似文献

相关主题

期刊订阅